Last week, the Food and Drug Administration (FDA) published a letter to veterinarians notifying them of severe adverse events linked to Librela (bedinvetmab injection) a common drug used to treat arthritis in dogs.

The families told Choi that they thought they were helping their dogs. Instead, they’re left wondering how their pets ended up hurt or dead.

In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela. The drug's maker, however, claims that it remains safe and effective.

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.

Dangerous side effects from the injectable canine drug Librela — used to treat osteoarthritis joint pain — have been linked to seizures, lameness and loss of muscle control, the FDA warned.

The U.S. Food and Drug Administration has warned veterinarians that an often-prescribed arthritis medication for dogs may be harmful.In a cautionary le

The United States Food and Drugs Administration is warning pet owners about a common medication given to pets to treat arthritis. The F.D.A. now says that the drug Librela may be associated with severe neurological effects. And in the worst cases, the medication may have even led to death.

The agency said it had reviewed more than 3,600 cases of side effects, including deaths, reported for dogs that took the drug Librela.